A
Anna Krasnodembskaya
Researcher at Queen's University Belfast
Publications - 57
Citations - 4626
Anna Krasnodembskaya is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Mesenchymal stem cell & ARDS. The author has an hindex of 16, co-authored 49 publications receiving 2919 citations. Previous affiliations of Anna Krasnodembskaya include University of California & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Emerging Therapeutic Potential of Mesenchymal Stem/Stromal Cells in Preeclampsia.
Sonja Suvakov,Sonja Suvakov,Claire Richards,Valentina N. Nikolic,Tatjana Simic,Tatjana Simic,Kristine C.Y. McGrath,Anna Krasnodembskaya,Lana McClements +8 more
TL;DR: A detailed overview of the therapeutic applications and mechanisms of mesenchymal stem/stromal cells (MSCs) as a potential new treatment for preeclampsia is given.
Journal ArticleDOI
Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment.
Naomi Todd,Ross McNally,Abdelrahim Alqudah,Abdelrahim Alqudah,Djurdja Jerotic,Sonja Suvakov,Sonja Suvakov,Danilo Obradovic,Denise Hoch,Jose R. Hombrebueno,Guillermo Lopez Campos,Chris J Watson,Miroslava Gojnic-Dugalic,Tatjana Simic,Anna Krasnodembskaya,Gernot Desoye,Kelly-Ann Eastwood,Kelly-Ann Eastwood,Alyson Hunter,Valerie Holmes,David R. McCance,David R. McCance,Ian S. Young,Ian S. Young,David J. Grieve,Louise C. Kenny,Louise C. Kenny,Vesna D. Garovic,Tracy Robson,Lana McClements,Lana McClements +30 more
TL;DR: The FKBPL-CD44 pathway appears to have a central role in the pathogenesis of preeclampsia, showing promising utilities for early diagnostic and therapeutic purposes.
Journal ArticleDOI
Expression pattern of arenicins—the antimicrobial peptides of polychaete Arenicola marina
Arina L. Maltseva,Olga N. Kotenko,V. N. Kokryakov,V. N. Kokryakov,Viktor V. Starunov,Anna Krasnodembskaya +5 more
TL;DR: The study showed that arenicins are found in different body compartments responsible for providing a first line of defense against infections, which implies their important role as key components of both epithelial and systemic branches of host defense.
Journal ArticleDOI
The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia.
Naveen Gupta,Naveen Gupta,Ranjeet Kumar Sinha,Anna Krasnodembskaya,Xiao Xu,Victor Nizet,Michael A. Matthay,John H. Griffin,John H. Griffin +8 more
TL;DR: It is demonstrated that both TLR4 and PAR1 are required for MSC survival under inflammatory conditions in vitro and therapeutic capacity in vivo, and that theTLR4 pathway regulates signaling through PAR1 on MSCs.
Journal ArticleDOI
Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells.
Soraia C. Abreu,Soraia C. Abreu,Thomas H. Hampton,Evan T Hoffman,Jacob Dearborn,Alix Ashare,Alix Ashare,Karatatiwant Singh Sidhu,Dwight E. Matthews,David H. McKenna,Eyal Amiel,Jayita Barua,Anna Krasnodembskaya,Karen English,Bernard P. Mahon,Claudia C. dos Santos,Fernanda F. Cruz,Fernanda F. Cruz,Daniel C. Chambers,Kathleen D. Liu,Michael A. Matthay,Robert A. Cramer,Bruce A Stanton,Patricia R. M. Rocco,Patricia R. M. Rocco,Matthew J. Wargo,Daniel J. Weiss,Sara Rolandsson Enes,Sara Rolandsson Enes +28 more
TL;DR: The potential use of MSC-based cell therapies for CF or other lung diseases may not be warranted in the presence of Aspergillus, according to the results of a comparison of effects of ex vivo MSC exposure to clinical bronchoalveolar lavage fluid samples.